A detailed history of William Blair Investment Management, LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, William Blair Investment Management, LLC holds 490,265 shares of ANIP stock, worth $31.2 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
490,265
Previous 490,557 0.06%
Holding current value
$31.2 Million
Previous $27 Million 25.3%
% of portfolio
0.09%
Previous 0.08%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$54.2 - $69.69 $15,826 - $20,349
-292 Reduced 0.06%
490,265 $33.9 Million
Q4 2023

Feb 09, 2024

SELL
$48.72 - $65.43 $462,937 - $621,715
-9,502 Reduced 1.9%
490,557 $27 Million
Q3 2023

Nov 09, 2023

SELL
$50.28 - $64.61 $1.96 Million - $2.52 Million
-39,069 Reduced 7.25%
500,059 $29 Million
Q2 2023

Aug 10, 2023

BUY
$37.29 - $53.83 $372,825 - $538,192
9,998 Added 1.89%
539,128 $29 Million
Q1 2023

May 12, 2023

BUY
$37.61 - $45.72 $62,620 - $76,123
1,665 Added 0.32%
529,130 $21 Million
Q4 2022

Feb 09, 2023

SELL
$31.9 - $41.95 $635,575 - $835,811
-19,924 Reduced 3.64%
527,465 $21.2 Million
Q3 2022

Nov 09, 2022

SELL
$29.83 - $38.01 $288,306 - $367,366
-9,665 Reduced 1.74%
547,389 $17.6 Million
Q2 2022

Aug 10, 2022

SELL
$23.09 - $33.46 $326,169 - $472,655
-14,126 Reduced 2.47%
557,054 $16.5 Million
Q1 2022

May 11, 2022

BUY
$26.91 - $47.15 $3.22 Million - $5.65 Million
119,736 Added 26.52%
571,180 $16.1 Million
Q4 2021

Feb 14, 2022

BUY
$32.97 - $56.85 $2.55 Million - $4.4 Million
77,338 Added 20.67%
451,444 $20.8 Million
Q3 2021

Nov 10, 2021

BUY
$26.48 - $35.99 $9.89 Million - $13.4 Million
373,351 Added 49450.46%
374,106 $12.3 Million
Q2 2021

Aug 12, 2021

BUY
$31.86 - $38.6 $24,054 - $29,143
755 New
755 $26,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.11B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track William Blair Investment Management, LLC Portfolio

Follow William Blair Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of William Blair Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on William Blair Investment Management, LLC with notifications on news.